Clinical Trial Update: Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the use of a statin to treat depression in patients undergoing coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Major Depressive Disorder

Drugs mentioned

• Statin (statin)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Heart Disease | Phase 3 | Status: UNKNOWN